<br>        Inclusion Criteria:<br><br>          -  According to the current Summary of Product Characteristics (SmPC)<br><br>          -  PTH(1-84) treatment initiated within one month preceding enrolment<br><br>          -  The patient's written informed consent to direct access and data processing must be<br>             obtained.<br><br>        Exclusion Criteria:<br><br>          -  According to the current SmPC<br><br>          -  The patient cannot participate in a clinical trial with PTH (all other trials<br>             allowed).<br>      ;<br>        Inclusion Criteria:<br><br>          -  According to the current Summary of Product Characteristics (SmPC)<br><br>          -  PTH(1-84) treatment initiated within one month preceding enrolment<br><br>          -  The patient's written informed consent to direct access and data processing must be<br>             obtained.<br><br>        Exclusion Criteria:<br><br>          -  According to the current SmPC<br><br>          -  The patient cannot participate in a clinical trial with PTH (all other trials<br>             allowed).<br>      ;<br>        Inclusion Criteria:<br><br>          -  According to the current Summary of Product Characteristics (SmPC)<br><br>          -  PTH(1-84) treatment initiated within one month preceding enrolment<br><br>          -  The patient's written informed consent to direct access and data processing must be<br>             obtained.<br><br>        Exclusion Criteria:<br><br>          -  According to the current SmPC<br><br>          -  The patient cannot participate in a clinical trial with PTH (all other trials<br>             allowed).<br>      ;<br>        Inclusion Criteria:<br><br>          -  According to the current Summary of Product Characteristics (SmPC)<br><br>          -  PTH(1-84) treatment initiated within one month preceding enrolment<br><br>          -  The patient's written informed consent to direct access and data processing must be<br>             obtained.<br><br>        Exclusion Criteria:<br><br>          -  According to the current SmPC<br><br>          -  The patient cannot participate in a clinical trial with PTH (all other trials<br>             allowed).<br>